Your browser doesn't support javascript.
loading
Spoken Language Alterations can Predict Phenoconversion in Isolated Rapid Eye Movement Sleep Behavior Disorder: A Multicenter Study.
Subert, Martin; Novotný, Michal; Tykalová, Tereza; Hlavnicka, Jan; Dusek, Petr; Ruzicka, Evzen; Skrabal, Dominik; Pelletier, Amelie; Postuma, Ronald B; Montplaisir, Jacques; Gagnon, Jean-François; Galbiati, Andrea; Ferini-Strambi, Luigi; Marelli, Sara; St Louis, Erik K; Timm, Paul C; Teigen, Luke N; Janzen, Annette; Oertel, Wolfgang; Heim, Beatrice; Holzknecht, Evi; Stefani, Ambra; Högl, Birgit; Dauvilliers, Yves; Evangelista, Elisa; Sonka, Karel; Rusz, Jan.
Afiliação
  • Subert M; Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
  • Novotný M; Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
  • Tykalová T; Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
  • Hlavnicka J; Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
  • Dusek P; Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Ruzicka E; Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Skrabal D; Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Pelletier A; Department of Neurology, Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, Quebec, Canada.
  • Postuma RB; Center for Advanced Research in Sleep Medicine, CIUSSS-NÎM - Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
  • Montplaisir J; Department of Neurology, Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, Quebec, Canada.
  • Gagnon JF; Center for Advanced Research in Sleep Medicine, CIUSSS-NÎM - Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
  • Galbiati A; Center for Advanced Research in Sleep Medicine, CIUSSS-NÎM - Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
  • Ferini-Strambi L; Center for Advanced Research in Sleep Medicine, CIUSSS-NÎM - Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
  • Marelli S; Sleep Disorders Center, Division of Neuroscience, Ospedale San Raffaele, Università Vita-Salute, Milan, Italy.
  • St Louis EK; Department of Psychology, "Vita-Salute" San Raffaele University, Milan, Italy.
  • Timm PC; Sleep Disorders Center, Division of Neuroscience, Ospedale San Raffaele, Università Vita-Salute, Milan, Italy.
  • Teigen LN; Department of Psychology, "Vita-Salute" San Raffaele University, Milan, Italy.
  • Janzen A; Sleep Disorders Center, Division of Neuroscience, Ospedale San Raffaele, Università Vita-Salute, Milan, Italy.
  • Oertel W; Mayo Center for Sleep Medicine, and Sleep Behavior and Neurophysiology Research Laboratory, Departments of Neurology and Medicine, Division of Pulmonary and Critical Care Medicine Mayo Clinic College of Medicine and Science Rochester, Rochester, MN, USA.
  • Heim B; Mayo Clinic Health System Southwest Wisconsin, La Crosse, WI, USA.
  • Holzknecht E; Mayo Center for Sleep Medicine, and Sleep Behavior and Neurophysiology Research Laboratory, Departments of Neurology and Medicine, Division of Pulmonary and Critical Care Medicine Mayo Clinic College of Medicine and Science Rochester, Rochester, MN, USA.
  • Stefani A; Mayo Center for Sleep Medicine, and Sleep Behavior and Neurophysiology Research Laboratory, Departments of Neurology and Medicine, Division of Pulmonary and Critical Care Medicine Mayo Clinic College of Medicine and Science Rochester, Rochester, MN, USA.
  • Högl B; Department of Neurology, Philipps University Marburg, Marburg, Germany.
  • Dauvilliers Y; Department of Neurology, Philipps University Marburg, Marburg, Germany.
  • Evangelista E; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Sonka K; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Rusz J; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Ann Neurol ; 95(3): 530-543, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37997483
OBJECTIVE: This study assessed the relationship between speech and language impairment and outcome in a multicenter cohort of isolated/idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD). METHODS: Patients with iRBD from 7 centers speaking Czech, English, German, French, and Italian languages underwent a detailed speech assessment at baseline. Story-tale narratives were transcribed and linguistically annotated using fully automated methods based on automatic speech recognition and natural language processing algorithms, leading to the 3 distinctive linguistic and 2 acoustic patterns of language deterioration and associated composite indexes of their overall severity. Patients were then prospectively followed and received assessments for parkinsonism or dementia during follow-up. The Cox proportional hazard was performed to evaluate the predictive value of language patterns for phenoconversion over a follow-up period of 5 years. RESULTS: Of 180 patients free of parkinsonism or dementia, 156 provided follow-up information. After a mean follow-up of 2.7 years, 42 (26.9%) patients developed neurodegenerative disease. Patients with higher severity of linguistic abnormalities (hazard ratio [HR = 2.35]) and acoustic abnormalities (HR = 1.92) were more likely to develop a defined neurodegenerative disease, with converters having lower content richness (HR = 1.74), slower articulation rate (HR = 1.58), and prolonged pauses (HR = 1.46). Dementia-first (n = 16) and parkinsonism-first with mild cognitive impairment (n = 9) converters had higher severity of linguistic abnormalities than parkinsonism-first with normal cognition converters (n = 17). INTERPRETATION: Automated language analysis might provide a predictor of phenoconversion from iRBD into synucleinopathy subtypes with cognitive impairment, and thus can be used to stratify patients for neuroprotective trials. ANN NEUROL 2024;95:530-543.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Transtornos Parkinsonianos / Transtorno do Comportamento do Sono REM / Demência / Disfunção Cognitiva Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Transtornos Parkinsonianos / Transtorno do Comportamento do Sono REM / Demência / Disfunção Cognitiva Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article